Medical Research Council, South Africa   Report issue

Government Phase 1 Phase 2 Phase 3
Founded: Cape Town South Africa (1969)

Organization Overview

First Clinical Trial
1999
NCT00213018
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Medical Research Council, South Africa

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 2)

Chemical and Drug Induced Liver Injury (Phase 3)

Communicable Diseases (Phase 2)

Coronavirus Infections (Phase 2)

Gonorrhea (Phase 2)

Hepatitis (Phase 3)

HIV Infections (Phase 3)

Infections (Phase 2)

Syphilis (Phase 2)

Trichomonas Vaginitis (Phase 2)

Tuberculosis (Phase 2)

Vaginitis (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 18
  • # of Trial APIs: 29